FDA Webview
X

Free FDA Notices

Panel to Discuss Janssen NDA for TB

09/26/2012

Federal Register Notice: FDA’s Anti-Infective Drugs Advisory Committee will meet 11/28, from 8 a.m. to 5 p.m. at DoubleTree by Hilton Hotel Washington DC — Silver Spring, The Ballroom, 8727 Colesville Rd., Silver Spring, MD. The committee will discuss the safety and efficacy of a Janssen Therapeutics’ NDA for bedaquiline tablets for treating patients with multi-drug resistant pulmonary tuberculosis. Contact Diane Goyette, (301) 796-9001. To view this notice, click here.

LATEST NEWS